Gene · 8021
Papers1,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 1,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploiting Clonal Evolution to Improve the Diagnosis and Treatment Efficacy Prediction in Pediatric AML. | Cancers (Basel) | 2021 | 33919131 | PubTator, text mining | PubMed |
| N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | Int J Mol Sci | 2021 | 33916271 | PubTator, text mining | PubMed |
| Long non-coding RNA KCNQ1 overlapping transcript 1 promotes the progression of esophageal squamous cell carcinoma by adsorbing microRNA-133b. | Clinics (Sao Paulo) | 2021 | 33909822 | PubTator, text mining | PubMed |
| O-GlcNAc modification of nuclear pore complexes accelerates bidirectional transport. | J Cell Biol | 2021 | 33909044 | PubTator, text mining | PubMed |
| Small ring has big potential: insights into extrachromosomal DNA in cancer. | Cancer Cell Int | 2021 | 33902601 | PubTator, text mining | PubMed |
| Molecular Landscapes and Models of Acute Erythroleukemia. | Hemasphere | 2021 | 33898929 | PubTator, text mining | PubMed |
| Performances of Targeted RNA Sequencing for the Analysis of Fusion Transcripts, Gene Mutation, and Expression in Hematological Malignancies. | Hemasphere | 2021 | 33880432 | PubTator, text mining | PubMed |
| Determining the Appropriate Treatment for T-Cell Acute Lymphoblastic Leukemia With SET-CAN/NUP214 Fusion: Perspectives From a Case Report and Literature Review. | Front Oncol | 2021 | 33869055 | PubTator, text mining | PubMed |
| Deregulation of enhancer structure, function, and dynamics in acute lymphoblastic leukemia. | Trends Immunol | 2021 | 33858773 | PubTator, text mining | PubMed |
| Construction of competing endogenous RNA network and identification of novel molecular biomarkers in colon cancer: A bioinformatic analysis. | Medicine (Baltimore) | 2021 | 33832120 | PubTator, text mining | PubMed |
| Interactions of HIV-1 Capsid with Host Factors and Their Implications for Developing Novel Therapeutics. | Viruses | 2021 | 33807824 | PubTator, text mining | PubMed |
| The Portal Vertex of KSHV Promotes Docking of Capsids at the Nuclear Pores. | Viruses | 2021 | 33807444 | PubTator, text mining | PubMed |
| Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis. | Ann Hematol | 2021 | 33796897 | PubTator, text mining | PubMed |
| Membraneless organelles restructured and built by pandemic viruses: HIV-1 and SARS-CoV-2. | J Mol Cell Biol | 2021 | 33760045 | PubTator, text mining | PubMed |
| Nuclear DEK preserves hematopoietic stem cells potential via NCoR1/HDAC3-Akt1/2-mTOR axis. | J Exp Med | 2021 | 33755722 | PubTator, text mining | PubMed |
| ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | Hum Mol Genet | 2021 | 33729478 | PubTator, text mining | PubMed |
| Computational approach to decipher cellular interactors and drug targets during co-infection of SARS-CoV-2, Dengue, and Chikungunya virus. | Virusdisease | 2021 | 33723515 | PubTator, text mining | PubMed |
| Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis. | BMC Biotechnol | 2021 | 33711981 | PubTator, text mining | PubMed |
| An Idic(7)(q11.2) Resulting in Two Copies of 7p and Deletion 7q: A Rare Cytogenetic Event in a Case of Acute Myeloid Leukemia. | J Assoc Genet Technol | 2021 | 33684909 | PubTator, text mining | PubMed |
| Interferon characterization associates with asthma and is a potential biomarker of predictive diagnosis. | Biosci Rep | 2021 | 33682888 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8021/papers?page=25